Payers who’ve balked at next-gen cholesterol meds now have more justification. A new JAMA study concluded that Amgen, Sanofi and Regeneron would have to slash…

Medivation posted second-quarter numbers on Tuesday, and they offer more evidence why Big Pharma and Big Biotech are stumbling over themselves to snap up the…

JAMA lit a fuse in pharma last week with a study associating free meals for doctors with increases in branded prescriptions. Here's one marketing expert…

Everyone in healthcare is trying to figure out wearables, including pharma. Omnicom Health Group is counting on a new digital health partnership to help its…

In the pharma world, waiting room marketing is often overlooked for its sexier DTC cousin. But point-of-care advertising now accounts for about 10% of pharma’s…

Diabetes researchers, endocrinologists and primary care docs, patient advocacy groups and, of course, media descended on New Orleans to catch the latest. Here…

Eli Lilly has been racking up new Trulicity data to build a broader case for the weekly GLP-1 med, and a new study now shows that adding it to Lantus beat…

Millennial doctors are conflicted about pharma. They believe drugmakers give them helpful info, but almost two-thirds don’t trust it. Half call DTC ads…

Data and Analytics